News from SLAS 2017

High-throughput mass spectrometry as a drug discovery tool was a highlight of SLAS 2017 as it has been over the last few years. In 2013 and 2015 the SLAS Innovation Award for best presentation of the conference went to high-throughput mass spectrometry projects. This year saw important advances in HT-MALDI-MS as Bruker Daltonics continues to make instrumentation improvements to it's MALDI PharmaPulse instrument platform and recognized as the SelectScience Scientist's Choice Awardee for "Best New Drug Discovery & Development Product of 2016". At the same time AMRI announced that they had entered an alliance with Bruker Daltonics and HighRes Biosolutions in implementing HT-MALDI-MS for drug discovery. link

These developments, along with the past awards, demonstrate the appeal, importance, and potential impact of HT-MS in drug discovery. MS2 Array's technology is fully compatible with all MALDI-MS instruments and provides vital enhancements to HT-MALDI-MS such as analyte enrichment, greater sensitivity, full assay design freedom, and complete bio-orthgonality.

SLAS 2017, Feb 5th-8th

MS2 Array CEO & Co-Founder Marvin S. Yu will be attending SLAS 2017 in Washington D.C. from Sunday, Feb 5th to Wednesday, Feb 8th.

If you are also attending SLAS 2017 and would like to learn more about how we can help improve your HTS efforts then please contact Marvin at